
The second cohort of PRiME Fellows was announced on September 1, 2020, with nine exceptional young scientists receiving funding to conduct research at the University of Toronto. Their projects focus on diagnostic or therapeutic solutions addressing diseases including fibrosis and COVID-19.
Now in its second year, the competition provides funding to PhD students or postdoctoral fellows with bold ideas enabling high-risk, high-reward research, with cross-disciplinary collaborations across the Faculties of Pharmacy, Arts & Science, Medicine, and Engineering.
The nine 2020 Fellows: Subha Dahal (Cochrane & Laposa), Eric Donders (Shoichet & Lautens), Brendan Innes (Bader & McGuigan), Zhongle Liu (Cowen & Batey), Marios Mejdani (Mahadevan & Rini), Jiaxi Peng (Wheeler, Peng & Morshead), Michael Saikali (Cummins & Krause), Suryasree Subramania (Sidhu & Angers), and Warren van Loggerenberg (Roth & Guenther) — spanning broad-spectrum antivirals, colloidal drug aggregates, fibrosis mapping, fungal inhibitors, COVID-19 diagnostics and vaccines, single-cell proteomics, nuclear-receptor quantification, antibody engineering, and variant-effect mapping.
More news
Awards & Fellowships · May 29, 2025
BoutIQ Solutions Inc. Named Winner of U of T's 2025 Biotech Venture Pitch Competition
Awards & Fellowships · April 21, 2025
Six Teams to Compete for Research Funding at the 2025 Building a Biotech Venture Pitch Competition
Awards & Fellowships · September 30, 2024